(TRIL) Trillium Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Trillium Therapeutics | (TRIL) share price targets
Complete technical analysis of Trillium Therapeutics (TRIL) by charts plus indicators, forecast predictions and share price targets for Trillium Therapeutics (TRIL)
Trillium Therapeutics trades in USA in Health Care sector.
10 day averaged volume of Trillium Therapeutics is 4900
| Date | Daily Closing Price | Open | High | Low | Volume |
| 07 Fri Nov 2025 | 20.10 | 20.17 | 20.17 | 19.89 | 0.245 times |
| 06 Thu Nov 2025 | 20.18 | 20.51 | 20.51 | 20.18 | 0.306 times |
| 05 Wed Nov 2025 | 20.54 | 20.36 | 20.64 | 20.36 | 0.204 times |
| 04 Tue Nov 2025 | 20.33 | 20.64 | 20.65 | 20.33 | 0.429 times |
| 31 Fri Oct 2025 | 20.74 | 20.75 | 20.77 | 20.73 | 0.286 times |
| 31 Fri Oct 2025 | 20.74 | 20.75 | 20.77 | 20.73 | 0.286 times |
| 30 Thu Oct 2025 | 20.53 | 20.65 | 20.74 | 20.53 | 0.367 times |
| 29 Wed Oct 2025 | 21.08 | 21.27 | 21.27 | 20.95 | 4.327 times |
| 28 Tue Oct 2025 | 20.95 | 20.88 | 20.99 | 20.79 | 2.49 times |
| 27 Mon Oct 2025 | 20.73 | 20.60 | 20.73 | 20.59 | 0.388 times |
My analysis of stock is bearish for shortterm, and stock might move down till 19.9 or till 19.4. Use a stoploss of 20.28 and if the stock hits stoploss, then it can shoot up till 20.67
Share price targets for Trillium Therapeutics (TRIL)
| Target Type | Value |
| Downside Target | 17.49 |
| Downside Target | 18.12 |
| Downside Target | 18.49 |
| Downside Target | 19.53 |
| Upside Target | 20.44 |
| Upside Target | 20.53 |
| Upside Target | 20.65 |
| Upside Target | 20.73 |
| Upside Target | 20.77 |
| Upside Target | 21.27 |
Intraday share price targets for Trillium Therapeutics (TRIL)
| Target Type | Value |
| Downside Intraday Target | 19.78 |
| Downside Intraday Target | 19.45 |
| Upside Intraday Target | 20.54 |
| Upside Intraday Target | 20.97 |
| Upside Intraday Target | 20.21 |
Weekly technical analysis of Trillium Therapeutics (TRIL)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 07 Fri Nov 2025 | 20.10 | 20.64 | 20.65 | 19.89 | 4.143 times |
| 31 Fri Oct 2025 | 20.74 | 20.75 | 20.77 | 20.73 | 0.036 times |
| 31 Fri Oct 2025 | 20.74 | 20.60 | 21.27 | 20.53 | 2.73 times |
| 24 Fri Oct 2025 | 20.25 | 20.04 | 20.28 | 19.78 | 1.27 times |
| 17 Fri Oct 2025 | 19.85 | 20.06 | 20.06 | 19.60 | 0.326 times |
Price has moved down this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Trillium Therapeutics (TRIL)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 07 Fri Nov 2025 | 20.10 | 20.64 | 20.65 | 19.89 | 0.046 times |
| 31 Fri Oct 2025 | 20.74 | 20.04 | 21.27 | 19.53 | 22.937 times |
| 30 Tue Sep 2025 | 20.44 | 20.00 | 20.44 | 19.88 | 0 times |
| 16 Tue Nov 2021 | 18.44 | 18.07 | 18.49 | 17.68 | 1.709 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Trillium Therapeutics (TRIL)
Price action analysis of Trillium Therapeutics ( (TRIL) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Trillium Therapeutics ( (TRIL) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Trillium Therapeutics ( (TRIL) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Trillium Therapeutics ( (TRIL) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Trillium Therapeutics stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Trillium Therapeutics in short term but the sell signal is initial and weak.
Trillium Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Trillium Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Trillium Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 20.89 and Trillium Therapeutics (TRIL) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Trillium Therapeutics (TRIL) stock. Volume based technical analysis of Trillium Therapeutics (TRIL) stock is negative.
Trillium Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Trillium Therapeutics ( (TRIL) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Trillium Therapeutics ( (TRIL) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Trillium Therapeutics ( (TRIL) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Trillium Therapeutics ( (TRIL) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Trillium Therapeutics stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Trillium Therapeutics in short term but the sell signal is initial and weak.
Trillium Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Trillium Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Trillium Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 20.89 and Trillium Therapeutics (TRIL) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Trillium Therapeutics (TRIL) stock. Volume based technical analysis of Trillium Therapeutics (TRIL) stock is negative.
Trillium Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.